Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation (RGEN)
Repligen Corporation (RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in
Repligen Contact:
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com
Image: https://ml.globenewswire.com/media/MDQ1ZWI5OWUtMDFmYi00MTRiLWI1ZGMtMjZkOTAxMTViNTIwLTEwMTY4MTE=/tiny/Repligen-Corporation.png
Image: Primary Logo
Source: Repligen Corporation (RGEN)